Table 2 ICH vs. non-ICH cohorts: demographics, pre-admission morbidity, pre-cannulation SOFA score, ECMO mode, and indication
Variable | ICH cohort (n = 54) | Non-ICH cohort (n = 199) | p value |
|---|---|---|---|
Demographics | |||
Age (years) | 51.5 (40–61) | 50 (32–60) | 0.158 |
Male sex | 35 (65%) | 127 (64%) | 1.000 |
Pre-admission morbidity | |||
Hypertension | 9 (17%) | 36 (18%) | 0.967 |
Insulin-dependent diabetes mellitus | 5 (9%) | 22 (11%) | 0.896 |
Chronic renal disease | 2 (4%) | 1 (1%) | 0.116 |
Antithrombotic therapy | 7 (13%) | 7 (4%) | 0.018 |
Charlson comorbidity index | 0 (0–1) | 0 (0–1) | 0.373 |
Pre-cannulation SOFA score | |||
Total | 14 (10.8–16) (26 missing, 48%) | 13 (10–15) (106 missing, 53%) | 0.443 |
Respiration | 4 (4–4) (25 missing, 46%) | 4 (4–4) (95 missing, 48%) | 0.340 |
Coagulation | 2 (0–3) (26 missing, 48%) | 1 (0–2) (100 missing, 50%) | 0.015 |
Liver | 1 (0–2) (26 missing, 48%) | 1 (0–2) (102 missing, 51%) | 0.960 |
Cardiovascular | 4 (3–4) (25 missing, 46%) | 4 (3–4) (95 missing, 48%) | 0.742 |
Neurological | 1 (0–2) (25 missing, 46%) | 1 (0–2) (98 missing, 49%) | 0.726 |
Renal | 1.5 (1–4) (26 missing, 48%) | 1 (0–4) (101 missing, 51%) | 0.606 |
ECMO Indication | |||
Pulmonary | 48 (89%) | 176 (88%) | |
Cardiac | 2 (4%) | 17 (9%) | |
ECPR | 4 (7%) | 6 (3%) | |
ECMO mode | |||
Venovenous | 31 (57%) | 130 (65%) | 0.361 |
Venoarterial | 23 (43%) | 69 (35%) | 0.361 |